ResMed’s strong growth during Covid-19
Sleep apnea device manufacturer ResMed has reported an operating profit up 31 per cent in the third quarter as it pivots towards products used to fight Covid-19. The company reported revenues up 16 per cent on the previous corresponding quarter to $ 1.19 billion (US$769.5 million). The company, which makes sleep apnea machines and hospital…